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PENGESANAN VIRUS PERNAFASAN SECARA MOLEKULAR DALAM 
KALANGAN JEMAAH HAJI KELANTAN 
 
ABSTRAK 
 
         Haji merupakan rukun Islam yang kelima di mana umat Islam berkumpul 
secara beramai-ramai di Mekah dan Madinah untuk melakukan beberapa upacara 
yang telah ditetapkan. Masalah utama yang telah dikenalpasti adalah masalah 
jangkitan salur pernafasan yang telah dibuktikan oleh kajian-kajian yang terdahulu, 
termasuk jemaah haji dari Malaysia. Oleh itu, kajian ini dilakukan untuk mengetahui 
jenis virus penyebab gejala tersebut dalam kalangan jemaah haji Kelantan. Kajian ini 
melibatkan jemaah haji Kelantan yang pulang dari menunaikan haji pada Oktober 
2013 hingga Disember 2013. Sampel kahak atau sapuan tekak diambil setelah 
mendapat persetujuan dari para jemaah. Kahak dikumpul dalam bekas steril (60mL), 
manakala sapuan disimpan dalam media pengangkutan universal dan disimpan di 
dalam kotak yang mengandungi ais sebelum dibawa ke makmal dengan kadar segera 
untuk disimpan dalam peti sejuk bersuhu -70˚C. RNA virus diekstrak dengan 
menggunakan Kit RNA Virus Mini (Qiagen, Germany) dan diproses menggunakan 
kaedah tindak balas ‘nested polymerase chain reaction (PCR)’ dan kaedah ‘real-time 
PCR’. Virus yang diuji adalah influenza A (FluA), respiratory syncytial virus A 
(RSVA), respiratory syncytial virus B (RSVB), dan human rhinovirus (hRV). Data 
dan maklumat klinikal yang diperolehi dianalisa dalam SPSS menggunakan ujian “t” 
untuk umur dan ujian Chi-square untuk mencari hubungan antara pengambilan 
vaksin influenza A dengan gejala jangkitan dan juga hubungkait antara pengesanan 
virus dalam kalangan jemaah haji Kelantan dengan gejala dan faktor risiko bagi 
jangkitan pernafasan yang dialami mereka. Dalam kajian ini, 40 (20.62%) jemaah 
  
xxii 
haji didapati positif untuk virus RSVA dan RSVB. Manakala tiga (1.52%) jemaah 
haji yang lain positif untuk rhinovirus. Semua jemaah haji didapati negatif untuk 
virus FluA. Tiada hubungkait yang ditemui antara pengambilan vaksin FluA dengan 
pengurangan mana-mana gejala. Tiada hubungkait juga antara virus yang ditemui 
dalam kalangan jemaah haji Kelantan dengan gejala mereka dan tiada juga penemuan 
hubungkait antara virus FluA, RSVA, dan hRV yang dikesan dalam kalangan jemaah 
haji Kelantan dengan faktor risiko. Akhir sekali, pengesanan RSVB dalam kalangan 
jemaah haji Kelantan berhubungkait dengan faktor risiko kencing manis (nilai-
p=0.049) dalam kalangan jemaah haji Kelantan. Kesimpulannya, virus RSV adalah 
yang paling kerap ditemui dalam kalangan jemaah haji Kelantan dan hanya virus 
RSVB mempunyai hubungkait dengan satu faktor risiko bagi jangkitan virus 
pernafasan, iaitu penyakit kencing manis. 
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MOLECULAR DETECTION OF RESPIRATORY VIRUSES AMONG 
KELANTANESE HAJJ PILGRIMS 
 
ABSTRACT 
 
               Hajj is a big Muslim gathering that occurs annually, where the Muslims 
perform several rituals to complete their pillars of faith. According to previous 
studies, respiratory symptoms were prevalent among Kelantanese hajj pilgrims. 
Thus, this study was conducted to determine the causes of the viral symptoms among 
these pilgrims. Specimens were taken in the form of sputum or throat swab after 
verbal consent was acquired from the Kelantanese pilgrims returning from Hajj from 
Kuala Lumpur to Kelantan between October 2013 to December 2013. After the 
sputum specimens were collected in 60mL sterile containers, the swabs were 
immersed in universal transport media and promptly taken back to the laboratory in 
USM Kubang Kerian, Kelantan to be stored at -70˚C freezer. They were then 
extracted using a Viral RNA Mini Kit (Qiagen, Germany) and processed using the 
nested PCR and real-time PCR methods as singleplex reactions. The viruses that 
were tested include influenza A (FluA), respiratory syncytial virus A (RSVA), 
respiratory syncytial virus B (RSVB), and human rhinovirus (hRV). The findings and 
clinical data were analysed in SPSS using t-test for age and Chi-square for the 
determination of the association of influenza vaccination with their clinical 
presentation and the association of viral detection among Kelantanese hajj pilgrims 
with their symptoms and risk factors. In this study, no FluA was detected, whereas 
RSVA was detected in 40 pilgrims (20.62%). RSVB was detected in 40 pilgrims 
(20.62%) and rhinovirus was detected in three pilgrims (1.52%). There was no 
association between FluA vaccination with the clinical presentation of the 
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Kelantanese hajj pilgrims. There was also no association between the detection of 
virus among Kelantanese hajj pilgrims with their clinical presentation. In addition, 
there was no association between FluA and RSVA detection among Kelantanese hajj 
pilgrims with their risk factors. Finally, diabetes mellitus was associated with RSVB 
detection (p-value=0.049). In conclusion, RSV was the most frequently detected 
respiratory virus among the Kelantanese hajj pilgrims and RSVB infection had 
association with diabetes mellitus. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 The Hajj 
 
 There is a very important holy practice for all Muslims around the world: it is 
known as the hajj. As required by Islamic faith, this practice is mandatory for all 
adult Muslims with the physical and financial ability to perform it – at least once in 
lifetime. In this practice, about two to three million Muslims (regardless of gender or 
background) gather in Mecca annually to perform the hajj. Of these, more than 
20,000 are Malaysians who come together for this purpose (Deris et al., 2010a). In 
Malaysia, the Tabung Haji Council is the council that aids future pilgrims in 
accumulating sufficient funds and make general preparations for hajj performance, 
which include education about hajj, the transportation between Malaysia and the 
Kingdom of Saudi Arabia (KSA), the lodging, bridging the communication between 
the two nations regarding the pilgrims’ quota updates, and adherence for smooth 
pilgrimage every year.  
 
 Figure 1.1 shows the hajj in simple steps. Firstly, before entering Mecca, the 
pilgrims declare their intentions known as "niyyat" and start wearing the white cloth 
called "ihram". In Mecca, they first perform the "tawaf", which refers to the 
counterclockwise circumambulation around the Kaaba for seven times. Kaaba is a 
cube-shaped structure of about 60 feet tall draped in black silk. It is considered the 
most sacred shrine of Islam and the direction all Muslims face during the obligatory 
daily prayers known as "solat". They will then camp in Mina and later perform the 
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"wuquf", which is a standing prayer, in Arafat. Following that, they gather some 
stones in Muzdalifah for the next ritual and make camp in Mina again to perform the 
Stoning the Devil ritual to commemorate Prophet Abraham doing so to avoid the 
Devil misleading him from taking heed the sacrifice command from Allah. They then 
perform the "tawaf" again and finally visit the Mosque of the Prophet to complete 
their pillars of faith (Benkouiten et al., 2013; Hajj Explained: Your Simple Guide to 
Islam’s Annual Pilgrimage, Al Arabiya News English, 2016). These steps can be 
viewed in great detail in Figures 1.2-1.8, which show the pilgrims performing hajj 
there with very close contact with each other from numerous nations. 
 
Figure 1.1: The general guide for the steps in performing the hajj. Retrieved from 
Hajj Explained: Your Simple Guide to Islam’s Annual Pilgrimage, Al Arabiya News 
English, 2016. 
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Figure 1.2: The tawaf done in multiple levels due to the immense population of 
pilgrims. Retrieved from Hajj: Diary of A Pilgrim, 
2015.
Figure 1.3: Mina tents where pilgrims rest after tawaf and before heading to Arafat. 
Retrieved from The Significance of the Rituals of Hajj, 2015. 
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Figure 1.4: Pilgrims making journey to Arafat from their tents in Mina. Retrieved 
from The Significance of the Rituals of Hajj, 2015. 
Figure 1.5: The wuquf performed in Arafat. Retrieved from The Significance of the 
Rituals of Hajj, 2015. 
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Figure 1.6: Pilgrims praying out in the open of Muzdalifah. Stones will be picked 
for their next journey. Retrieved from The Significance of the Rituals of Hajj, 2015. 
 
 
 
 
Figure 1.7: The pilgrims from Muzdalifah to Mina looking forward to the Stoning 
the Devil ritual. Retrieved from Hajj Pilgrimage Fast Facts, CNN News, 2017. 
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Figure 1.8: The stoning in Jamarat, Mina. Retrieved from The Significance of the 
Rituals of Hajj, 2015. 
 
 
 
1.2 Challenges Faced by Pilgrims during Hajj 
 
 Common problems faced by pilgrims during the hajj ritual can be divided 
into communicable and noncommunicable diseases. Noncommunicable problems are 
void of infectious processes or mostly void of microbiological pathogens. These 
include calorie mismanagement (e.g.: diabetes mellitus), substance abuse (e.g.: 
irresponsible drinking and smoking), mental illnesses, violent criminal activities, 
accidents, and tumours, although some tumours can have a microbiological 
aetiology, along with some mental illnesses (Hunter et al., 2013; Salam, 2016). Some 
of the pilgrims go to the Kingdom of Saudi Arabia (KSA) to perform Hajj with 
underlying diseases such as diabetes mellitus and hypertension, which require them 
to carry their own medication (Chamsi-Pasha et al., 2014).  
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There have been deaths during hajj (less than 20 Nigerian pilgrims) caused by 
heart diseases, hypertension, diabetes, and other illnesses in the past (Newspaper 
article - The Nation Online, 2015). The mortality rate during hajj due to non-health-
related problems have also been reported, such as the stampede in 2006 that claimed 
the lives of more than 70 pilgrims. Natural deaths during hajj have also occurred, 
whereby less than 20 Egyptian pilgrims have died due to heat exhaustion and 
hypertension. Other disasters during hajj that have claimed lives of pilgrims included 
fires, as well as the bombing of mosques (Newspaper articles - The Guardian, 2006; 
Ahram, 2016). 
 
 Communicable problems are diseases that can be infectious or transmitted to 
others. For example, gastroenteritis, meningitis, urinary tract infection, and the 
respiratory tract infection (RTI), which has been the most frequently reported 
infection among pilgrims during hajj season (Madani et al., 2006).  
 
1.3 Respiratory Tract Infections (RTI)   
 
 RTI refers to any infectious disease of the upper or lower respiratory tract. 
The former includes the common cold, laryngitis, pharyngitis, tonsillitis, acute 
rhinitis, acute rhinosinusitis, and acute otitis media, while the latter includes acute 
bronchitis, bronchiolitis, pneumonia, and tracheitis. These are usually caused by 
viruses, but can also be caused by bacteria. Co-infections also exist. Viruses such as 
Influenza viruses, Respiratory Syncytial Viruses (RSVs), and Rhinoviruses can cause 
RTI (Tregoning et al., 2010; Wei et al., 2015). 
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 In a previous study among Malaysian hajj pilgrims, only about 3% were free 
from respiratory symptoms, indicating that almost all of the hajj pilgrims had 
contracted RTIs (Deris et al., 2010). 
 
1.3.1 Risk Factors of RTI  
 
 During hajj in KSA (approximately forty days), the risk of RTI is very high 
due to the highly dense population and overcrowded environment (Deris et al., 2010). In 
addition, old age (65 years old) and having underlying medical conditions such as 
chronic heart disease and lung diseases like asthma and renal disease weregenerally 
described to be the risk factors for respiratory tract infection (Ludwig et al., 2012). 
Hung et al. (2013) also found that diabetes mellitus could increase the likelihood of a 
person acquiring pneumonia. Therefore, the risk factors for RTI among hajj pilgrims 
that were studied included underlying medical condition, smoking, old age, and 
immunosuppressed pilgrims. Though tobacco smoking was also included, it was not 
associated with influenza infection (Rashid et al., 2008).  
 
1.3.2 Aetiological Agents and Clinical Presentation of the RTI  
 
 There are many types of pathogens reported to be causing RTI among 
pilgrims. Bacterial causes among Iranian pilgrims include Haemophilus sp., and 
Razavi et al. has managed to detect atypical pathogen such as Mycoplasma 
pneumoniae.  In addition, fungal pathogen such as Candida albicans was detected 
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among critically ill pilgrims admitted during hajj (Mandourah et al., 2012) (Table 
1.1). 
 According to El Sheikh et al. (1998), around 19% of respiratory tract 
infections among hajj pilgrims were caused by viruses, with influenza A being the 
most common virus. In another study, respiratory syncytial virus, parainfluenza, and 
influenza were the causative pathogens identified (Memish, 2010). Benkouiten et al. 
(2013) found that the human rhinovirus and influenza virus were the most common 
viral agents among hajj pilgrims participating in this journey. These infections have 
known to affect the general population and hajj pilgrims alike. Respiratory syncytial 
virus and parainfluenza can cause severe lower respiratory tract infection that require 
hospital admission and considerable morbidity in the adult population (Osiowy, 
1998). Influenza, on the other hand, has a high incidence as the cause of upper 
respiratory tract infection with an estimation of 24,000 cases per hajj season (Balkhy 
et al., 2006). As for rhinoviruses, they usually cause mild symptoms, but may also 
cause lower respiratory tract infection that may result in severe illness among the 
elderly (Andeweg et al., 1999). As many of the hajj pilgrims are elderly or 
approaching the age of seniority, detecting these viruses are of worth to note. 
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Table 1.1: Various pathogens that cause RTI among hajj pilgrims 
Author(s) Year of Study Microorganisms Detected  Percentage of Microorganisms  
Memish et al. 2014 Influenza A 1.3 
Respiratory Syncytial Viruses 5.1 
Rhinovirus 16.8 
Mandourah et al. 2012 Candida albicans 6.7 
Escherichia coli 10.0 
Streptococcus sp. 10.0 
MRSA 10.0 
Staphylococcus aureus 10.0 
Pseudomonas aeruginosa 16.7 
Klebsiella sp. 16.7 
Acinetobacter sp. 26.7 
Rashid et al. 2008 Parainfluenza Type III 1.0 
Razavi et al. 2007 Mycoplasma pneumoniae 0.8 
Legionella pneumophila 6.3 
Haemophilus sp. 9.1 
Influenza B 11.4 
Enteric rod-shaped bacteria 19.4 
Chlamydia 32.0 
Adenovirus 36.2 
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1.4 Common Viruses Causing RTI among Hajj Pilgrims 
 
1.4.1 Influenza A Viruses 
 
 Influenza A viruses are negative-sense, single-stranded viruses with 
ribonucleic acid (RNA) that has multiple segmentations.  This virus is classified 
taxonomically in Group V [(-)ssRNA], Family of Orthomyxoviridae, and Genera 
called Influenzavirus A. There are many subtypes of these viruses that are named 
according to the haemagglutinin (H) and neuraminidase (N) antigens (proteins), and 
currently, there are 18 Hs and 11 Ns antigens that are known (CDC, 2016). Thus, 198 
different combinations are possible. Looking at the H and N, these subtypes have 
been confirmed in humans: H1N1 caused the Spanish flu and the 2009 swine flu 
outbreak; H1N2 and H2N2 caused the Asian flu (1957); H3N2 caused the Hong 
Kong flu (1968);and H5N1 (the pandemic threat in the mid-2000s), H5N2, H7N2, 
H7N7, H7N0, H9N2, and H10N7 (Taubenberger et al., 2010a). Sometimes, 
influenza viruses are identified and named according to their host, deadliness, and 
their similarity to their lineage. For the variation of hosts, there are variants such as 
the bird/avian influenza, human influenza, swine influenza, equine influenza, and 
canine influenza. As for the deadliness, they are divided into low pathogenic avian 
influenza (LPAI) and highly pathogenic avian influenza (HPAI), which is also 
known as the deadly flu or death flu. Some are named according to the similarity of 
their lineage to previously isolated strains, such as the Fujian flu (CDC, 2014). 
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1.4.1(a) Structure and Genetics 
 
 Influenza A virus contains a virion (virus particle) of about 80-120 
nanometres in diameter and a central core. The virion is usually spherical in shape 
and comprises of two major kinds of proteins known as H and N that are wrapped 
around a central core. H is a protein that is involved in binding the virion to the host 
cells and entry into the said cell, whereas N is involved in releasing the virions from 
the infected cells. These are also antigens for the host antibodies to bind to and 
mount the immune response, as well as becoming targets for antivirals. Of all the 18 
Hs and 11 Ns, only H1, H2, H3, N1, and N2 are commonly found in humans. The 
core of a virion has a viral genome and some proteins that cover and protect the said 
genome. The genome is made up of eight segments of RNAs. One segment contains 
either one or two genes coding for one protein, which means that the RNA genome 
cannot be translated into protein directly, but must firstly be transcribed into positive-
sense RNA before being translated into protein. Altogether, the eight segments of the 
RNA have 11 genes encoding for 11 proteins: H, N, nucleoprotein (P), matrix 
proteins (M1 and M2), non-structural proteins (NS1 and NS2), and RNA polymerase 
subunits PA, PB1, PB1-F2, and PB2 (Taubenbergeret al., 2010b; Zambon, 1999). 
 
1.4.1(b) Transmission 
 
 Influenza virus can be transmitted into a new host via direct transmission 
such as direct sneezing of mucous from an infected person into the eyes, nose, or 
mouth of another person; airborne droplets inhalation; and skin contact (hand) from 
contaminated surfaces to the eye, nose, or mouth, or a handshake with an infected 
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person (Hall, 2007). In healthy adults, the influenza virus can shed on peak two days 
after infection, while children can shed the virus from just before they develop the 
symptoms until after two weeks of infection and are profoundly more infectious than 
adults. Unfortunately, this can be much longer in immunocompromised people.  To 
prevent this, inactivation of this virus can be done, as mentioned earlier, and frequent 
handwashing should be emphasised (Pinsky, 2010). 
 
1.4.1(c) Pathophysiology 
 
 The H protein determines which host a strain can infect and where it can bind 
along the respiratory tract. When the viral strains have H proteins that bind to 2,6-
sialic acid receptors (which are found in the upper tract like the nose and throat), they 
are highly communicable. Some strains like the H5N1 bind to the 2,3-sialic acid 
receptors that are found in the lower respiratory tract, and thus thought to cause 
severe viral pneumonia and not easily spread by cough and sneezing. The reason 
behind this is due to the presence of specific cleavage proteases in the respiratory 
tract. Specific cleavage proteases will cleave only certain H protein, rendering the 
strain to invade the cells. After the invasion, the infected cells will produce plenty of 
pro-inflammatory cytokines and chemokines like interferon and tumour necrosis 
factor that causes fever, headaches, and fatigue in the host. This massive immune 
response was thought to produce the cytokine storm effect that caused the unusual 
lethality of H5N1 and the 1918 pandemic strain. Another study, however, claimed 
that it is not the immune response causing it. In contrast, they believed that the over-
responding immune system response is just due to a plethora of  viral replications 
made by these strains (Behrenset al., 2006). 
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1.4.1(d) Epidemiology 
 
 In the general global population, influenza usually occurs in winter, most 
probably due to the reason of people being indoors most often and coming into close 
contact, which promotes transmission. The other reasons are increased travelling 
during winter, and as mentioned earlier, influenza viruses survive longer at colder 
temperature. Furthermore, it is also known that the virus spreads at the highest rate at 
less than 5˚C with relatively low humidity. As for tropical countries, the peaks of 
infection are during rainy seasons. Normally, there is an estimation of three to five 
million cases of severe influenza illnesses and roughly a half million deaths 
worldwide. According to the Center of Disease Control and Prevention (CDC), it is 
now reporting deaths caused by influenza from as low as 3,300 up to 49,000 annually 
(CDC). In a hajj population of symptomatic pilgrims, however, the prevalence of 
influenza is from as low as 0.1% up to 76% (Balkhyet al., 2004; Benkouitenet al., 
2013; Rashidet al., 2008a).  
 
From history, a pandemic of influenza virus with global widespread has 
occurred about three times in a century and caused the deaths of tens of millions of 
people. The first convincing record was a pandemic that occurred in the 16thCentury, 
which began in Russia and spread to Europe, where thousands of people perished. 
Some pandemics later occurred in the 17th and 18th Centuries. Later, in 1918, the 
infamous Spanish Flu killed 50 to a hundred million people worldwide 
(Taubenberger et al., 2010a). Due to censorship by many countries involved in the 
world war, data from the neutral Spain is not available for study, and thus, the total 
mortality was never known and the term ‘Spanish Flu’ was coined. Another source 
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estimated around 2.5% to 5% of the global population perished then. The Spanish 
Flu is very famous for a few unusual features. It is caused by the H1N1 subtype. 
Apart from killing many people, it killed mostly young and healthy people, with 99% 
deaths from among people under the age 65 years old, and more than 50% of them 
20 to 40 years old (Taubenberger et al., 2010a). The symptoms were also peculiar 
that it was often thought to be dengue or cholera or typhoid fever. Another striking 
feature was haemorrhage from mucous membranes such as nose, stomach, intestine, 
ears, skin (petechial), and lungs (with oedema). The sub-sequential pandemics were 
less devastating: the Asian Flu (1957), Hong Kong Flu (1968), Russian Flu (1977), 
and the Swine Flu (2009). These have killed roughly 300,000 to one and a half 
million people each (Taubenberger et al., 2010a). 
 
1.4.1(e) Laboratory Diagnostic Methods 
 
 Currently, there are many diagnostic tests available to diagnose influenza 
infection. However, the results must be correlated with the vaccination history of the 
individual, as positive influenza tests that yield vaccine virus strain have been 
reported up to 7 days after receiving live attenuated influenza virus vaccine. To carry 
out the tests, generally, nasopharyngeal and nasal specimens have better yields than 
throat swabs, though all perform best when collected as close to illness onset as 
possible, preferably 72 hours after onset. As for lower respiratory tract illness, 
endotracheal aspirate or bronchoalveolar lavage specimens are better for use. 
 
 To date, viral culture is the gold standard method to diagnose influenza virus 
infection, as it provides information about the antigenic characteristics, antiviral 
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resistance, and subtyping. These prove useful in surveillance systems, as they can 
help in comparing current circulating influenza virus strains with vaccine strains, 
guiding decisions for influenza treatment and chemoprophylaxis, and selecting 
vaccine virus strains in the next season. However, it can take up to 10 days to 
complete. Thus, it is not preferable for the purpose of clinical management of 
patients. 
 
 The most accurate and sensitive test is the reverse transcription polymerase 
chain reaction (RT-PCR). There is even a standardised protocol and platform 
developed and distributed by the CDC. However, it lacks the subtyping capability to 
aid in surveillance systems. Clinically, due to the time required to complete this test 
(up to 6 hours), this method is not very useful in the medical management of patients.  
 
 Currently, the fastest available method is the commercial rapid influenza 
diagnostic test (RIDTs) that can detect influenza virus within 15 minutes. It comes in 
2 variants: one can detect and distinguish both influenza A and B, while the other can 
only detect, but not distinguish between the two viruses. However, none of them can 
do the subtyping for influenza A. The limitation for this method is that it has low to 
moderate sensitivity of between 20% to 70% (CDC-ACIP: MMWR, 2015). 
 
 Immunofluorescence assay can also be used for diagnostic purposes. It takes 
up to 4 hours to perform and has the sensitivity of about 70% to 100% and specificity 
of more than 80%. However, it is labour intensive, requires laboratory and technical 
expertise, and less sensitive if compared to nucleic acid tests and the culture method 
(Kim et al., 2013). 
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 Lastly, serologic tests are known to diagnose influenza virus infection. 
However, except for epidemiological and research purposes, it is not recommended, 
as it requires paired acute and convalescent sera, which is not widely available 
(WHO, 2011; CDC-ACIP: MMWR, 2015). 
 
1.4.1(f) Treatment, Efficacy, and Resistance 
 
 There are two classes of antivirals available to treat influenza that is approved 
by the FDA. They are the neuraminidase inhibitors, which consist of oseltamivir, 
zanamivir, peramivir, and lanamivir, and the adamantanes, which comprise of 
amantadine and rimantadine. F16 antibody was recently notified to be a promising 
Influenzavirus A antiviral (Russell, 2011). 
 
 Oseltamivir is an influenza antiviral medication currently marketed under the 
brands Tamiflu, which is manufactured by Roche, or Antiflu, which is manufactured 
by Cipla. It comes in 30mg, 45mg, and 75mg capsules and suspension. When orally 
taken, it will be hydrolysed to its active metabolite called free oseltamivir 
carboxylate, which is a competitive inhibitor for influenza viral N enzyme action 
upon sialic acid, rendering the new viral particles replicated in the host cell and 
blocked from being released outside of the host cell. The recommended duration of 
treatment is five days, but a longer duration can be prescribed, especially for the ones 
who are still severely ill even after the recommended duration of treatment has been 
completed. It is known that nausea and vomiting are the frequent side effects among 
adults and children, but these can be reduced if taken with food. 
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 Zanamivir is an influenza antiviral medication currently marketed under the 
brand Relenza and manufactured by GlaxoSmithKline. It is available in 5mg blister 
dose to be administered via inhalation through an inhaler device. When taken via 
inhalation, it will bind to the active site of N protein and prevent the release of 
virions from the host cell, apart from inhibiting the viral replication in vivo. About 
15% of the dose is absorbed and eliminated via urine. The recommended dosage of 
zanamivir is two inhalations for 12 hours apart and twice daily. An inhalation is 
equivalent to a 5mg dose, which makes the recommended dosage for twice a day a 
total of 10mg. The most common unwanted reactions of taking zanamivir are loose 
motion, nausea, clogged, and/or inflamed sinuses, bronchitis, cough, headache, light-
headedness, infections of ear, nose, and throat, and bronchospasm in asthmatic 
persons. Therefore, zanamivir is not endorsed to treat persons with underlying 
pulmonary disease. 
 
 When given to more than two days of onset of uncomplicated influenza, 
minimal or no benefit was observed. In a randomised and controlled trial, when 
given to outpatient adults within 48 hours of illness onset, the duration of illness was 
shorter by one day. Clinically, one large, prospective cohort study showed that 
oseltamivir treatment that was initiated after 48 hours of illness onset significantly 
reduced the risk of death within 15 days of hospitalisation, but not more than 30 days 
of hospitalisation. In a retrospective cohort study, oseltamivir treatment initiated after 
48 hours of illness onset significantly reduced the length of hospital stay among 
laboratory-confirmed influenza patients by two days. Another cohort (prospective) 
study showed that oseltamivir treatment in laboratory-confirmed influenza patients 
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was associated with earlier discharge and better survival. It was reported that 
oseltamivir treatment reduced the risk for pneumonia among the influenza 
participants of a study that combined ten clinical trials by 50% (p<0.05). It was also 
reported that oseltamivir has reduced the hospitalisation of patients, though not 
significantly. Other data regarding neuraminidase inhibitors preventing serious 
complications of influenza is limited.  
 
 The development of oseltamivir or zanamivir resistance has been reported 
when used to treat seasonal influenza. However, the resistance of oseltamivir is more 
common than zanamivir during treatment. Most patients with oseltamivir-resistant 
influenza strain infection did not have oseltamivir treatment or chemoprophylaxis 
before. Most sporadic cases of oseltamivir-resistant seasonal influenza strains are due 
to H275Y mutation, where a substitution of histidine to tyrosine in neuraminidase 
occurred among these strains. Fortunately, they are susceptible to zanamivir. 
 
 New drugs have been developed that showed activity against influenza A. 
They are peramivir, lanamivir, and the F16 antibody. Recently, the F16 antibody has 
been reported to target all 16 Hs, which is very promising in treating influenza. 
However, more data and pharmacological information need to be known. 
 
 Previously, amantadine and rimantadine have been prescribed to treat 
influenza. Amantadine is a derivative of adamantane backed by the US Food and 
Drug Administration for prescription as anti-influenza and antiparkinson drug in 
1966. As an anti-influenza drug, it interferes with the viral protein M2, which is a 
proton channel that subsequently disrupts the onset of viral replication in the virion. 
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The dosage is 100mg for two times in a day. However, due to a history of veterinary 
misuse, the current strains of influenza (H1N1 & H3N2) have become resistant to 
amantadine, and it is thus no longer recommended for use as treatment or 
chemoprophylaxis.  
 
 Rimantadine is another adamantane derivative used to treat and prevent 
influenza. It also inhibits the viral replication of influenza by preventing the removal 
of the viral envelopes and capsid, as well as interfering with the M2 protein of the 
virus. The dosage is 100mg for twice a day. Unfortunately, this drug can cause 
unwanted reactions such as nausea, anxiety, fatigue, insomnia, dizziness, and 
difficulty in concentrating. As the current strains of influenza (H1N1 & H3N2) are 
now resistant to rimantadine, it is no longer recommended for use as an anti-
influenza drug for treatment or chemoprophylaxis (CDC-ACIP: MMWR, 2015). 
 
1.4.2 Respiratory Syncytial Viruses (RSVs)  
 
 Respiratory Syncytial Viruses (RSVs) are negative-sense, single-stranded, 
enveloped RNA (ribonucleic acid) viruses. It also has an antigenome, a positive-
sense replicative intermediate that can avoid recognition by host receptors such as 
toll-like cell receptors (TLRs). This virus is taxonomically classified in Group V [(-) 
ssRNA] of the Family Paramyxoviridae, Subfamily Pneumovirinae, Order 
Mononegavirales, and Genera Pneumovirus. 
 
 Human RSV has a single serotype and two antigenic types, namely RSV 
Type A (RSV A) and RSV Type B (RSV B). RSV A has about 10 genotypes, while 
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RSV B has about 13 genotypes. There are also bovine RSVs and pneumonia virus of 
mice (PVM). However, there is no other known reservoir for human RSVs. The first 
RSV was isolated from chimpanzees in 1956 (called Chimpanzee Coryza Agent, or 
CCA) by Robert Chanock and determined to be of human origin instantly. It is a 
familiar cause for respiratory tract infection, and the current prophylaxis for it is 
using palivizumab, an RSV-specific antibody that is very expensive and reserved 
only for those at high risk. The vaccine to prevent this viral infection and give herd 
immunity has yet to be discovered. Thus, it remains a priority to understand this 
virus better and control its viral infection (Borcherset al., 2013).  
 
1.4.2(a) Structure and Genetics 
 
 RSVs contain an envelope that comprises of three major proteins: 
glycoprotein (G), fusion protein (F), and small hydrophobic (SH) protein. The G 
protein is involved in cell attachment and differentiating the two antigenic types; the 
F protein is responsible for merging and allowing access into the host cell. The 
structural proteins of this virus include: L large protein (250kDa), nucleocapsid (N, 
42kDa), phosphoprotein (P, 35 kDa), matrix proteins (M2-1 & M2-2), and two non-
structural proteins (NS1 & NS2).  The virus has 10 genes that encode for 11 proteins 
because of the two overlapping open-reading frames in the M2 mRNA codes for the 
two different matrix proteins (Gonzalezet al., 2012; Gonzalezet al., 2013). 
 
 
 
 
  
22 
1.4.2(b) Transmission 
 
 RSV virus can be transmitted into a new host via inoculation into the eyes or 
nose by large particle aerosol or direct contact, as it can remain viable for about 30 
minutes or more on the hands and more than five hours on surfaces. Then, with the 
incubation period of four to five days, the virus replicates in the nasopharynx, and it 
can spread further down the lower respiratory tract. To prevent this, frequent 
handwashing should be cultivated, and hygienic surfaces should be maintained 
(Collinset al., 2008). 
 
1.4.2(c) Pathophysiology 
 
 In vitro, it has been demonstrated that RSV infection can initiate respiratory 
epithelial cells to many different kinds of cytokines and chemokines, causing 
inflammatory responses in the airways. They include macrophage inflammatory 
protein-1a (MIP1a), monocyte chemotactic protein (MCP1), RANTESIL8, IFN 
gamma, IP10, fractalkin (CX3CL1), IL1-beta, IL6, and TNF. These are responsible 
for induction and attracting neutrophils, basophils, and eosinophils into 
bronchoalveolar fluid and the lungs(Stokeset al., 2011). In mice, about a week after 
infection, dense perivascular and peribronchial infiltrates reach the alveolar spaces, 
where macrophages, lymphocytes, and neutrophils are rich (Loebbermannet al., 
2012). Humorally, in mice, it was shown that antibodies could be produced, namely a 
RSV-specific serum IgM and then IgG (Johnsonet al., 2007). Later, 
histopathologically, it sloughed off airway epithelial cells with macrophages, fibrin 
strands, and mucin, occluding the lumen. Simultaneously, infiltrates cause mucosal 
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and submucosal oedema. These contribute to acute bronchiolitis, bronchitis, and 
airway obstruction (Villenaveet al., 2011; Villenaveet al., 2013). 
 
1.4.2(d) Epidemiology 
 
 In the general global population, RSV infection can occur in any season and 
region. Both subtypes circulate simultaneously, but usually only one subtype will 
predominate. An epidemic of RSV infection has been thought to be associated with 
declining titres of maternally derived RSV, neutralising antibodies in infants, as 
observed in Denmark. However, this cannot explain the different seasonal pattern of 
RSV infection in temperate regions (having two peaks: between 2-6oCelsius and 24-
30oCelsius) and where it can be a bit constant throughout the year in tropical regions 
(Collinset al., 2008). In hajj population, it is one of the common viruses reported 
(Benkouitenet al., 2013; Memishet al., 2014; Rashidet al., 2008a; Razaviet al., 
2007), but there has been no known pandemic of this virus. 
 
1.4.2(e) Laboratory Diagnostic Methods 
 
 Currently, there are many diagnostic tests available to diagnose RSV 
infection. Specimens needed to carry out the tests include nasopharyngeal aspirates, 
swabs, and washes. As for lower respiratory tract illness, endotracheal aspirate or 
bronchoalveolar lavage specimens can be used. A recent observation showed that 
descriptively, both nasopharyngeal swab, which is less uncomfortable and less 
invasive, and nasopharyngeal aspirate showed equal sensitivities in detection via 
real-time PCR. Though other methods of diagnosis were not compared. 
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 To date, viral culture is the gold standard method to diagnose RSV infection, 
as it has good sensitivity that can decrease in adult testing due to the adults’ tendency 
to have lower viral titre. However, it is time consuming and therefore not preferable 
for the purpose of the clinical management of patients. Furthermore, trained 
personnel are needed to maintain the appropriate cell lines for this purpose, and an 
expert is needed to interpret the characteristic cytopathogenic effect in the culture. 
The faster and more economic version of this method is to culture the viruses and use 
immunofluorescence antibody to detect the RSV. 
 
 Serologically, there are many methods to detect RSV by measuring 
antibodies (needs paired serum specimens), which include neutralisation, 
haemagglutinin inhibition, complement fixation, and enzyme-linked immunosorbent 
assay (ELISA). Complement fixation is less sensitive. As for ELISA, there are 
several kits available in the market that are able to detect the RSV antigen. This 
method is faster compared to viral culture, though the results are rather subjective, 
making it fit for large screening due to its dependence on the nasopharyngeal cell 
count. 
 
 Molecular methods can also detect RSV, which can save a lot of time 
compared to the viral culture method. Furthermore, expertise is not needed, as it is 
automated and a large sample size can be processed. The conventional PCR does 
have its limitation, as it depends on the viral copies in the specimen to be amplified, 
detected, and interpreted. Real-time PCR can overcome this because it is more 
sensitive than conventional PCR. One study also noted that real-time PCR was better 
